Anti-VEGF-A antibodies and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10919958
APP PUB NO 20190202903A1
SERIAL NO

16327362

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies having activity against a vascular endothelial growth factor (VEGF), and methods of making and using such antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDIMMUNE LIMITEDCAMBRIDGE CB2 0AA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cepeda, Mario A Winchester, US 4 1
Coffman, Karen Gaithersburg, US 4 1
Dimasi, Nazzareno Gaithersburg, US 30 338
Gao, Changshou Gaithersburg, US 58 799
Leow, Ching Ching Gaithersburg, US 12 33
Schwartz, Mittelman Adrian Brookfield, US 5 1
Tsui, Ping Gaithersburg, US 50 263

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 16, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 16, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00